Trial · NCT01730040
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Atorvastatin 40 mg | 57 | |
| Overall Study | STARTED | Ezetimibe 10 mg + Atorvastatin 20 mg | 55 | |
| Overall Study | STARTED | Alirocumab 75 mg/up to 150 mg + Atorvastatin 20 mg | 57 | |
| Overall Study | STARTED | Atorvastatin 80 mg | 47 | |
| Overall Study | STARTED | Rosuvastatin 40 mg | 45 | |
| Overall Study | STARTED | Ezetimibe 10 mg + Atorvastatin 40 mg | 47 | |
| Overall Study | STARTED | Alirocumab 75 mg/up to 150 mg + Atorvastatin 40 mg | 47 | |
| Overall Study | Treated | Atorvastatin 40 mg | 57 | |
| Overall Study | Treated | Ezetimibe 10 mg + Atorvastatin 20 mg | 55 | |
| Overall Study | Treated | Alirocumab 75 mg/up to 150 mg + Atorvastatin 20 mg | 57 | |
| Overall Study | Treated | Atorvastatin 80 mg | 47 | |
| Overall Study | Treated | Rosuvastatin 40 mg | 45 | |
| Overall Study | Treated | Ezetimibe 10 mg + Atorvastatin 40 mg | 46 | |
| Overall Study | Treated | Alirocumab 75 mg/up to 150 mg + Atorvastatin 40 mg | 47 | |
| Overall Study | COMPLETED | Atorvastatin 40 mg | 44 | |
| Overall Study | COMPLETED | Ezetimibe 10 mg + Atorvastatin 20 mg | 40 | |
| Overall Study | COMPLETED | Alirocumab 75 mg/up to 150 mg + Atorvastatin 20 mg | 46 | |
| Overall Study | COMPLETED | Atorvastatin 80 mg | 39 | |
| Overall Study | COMPLETED | Rosuvastatin 40 mg | 39 | |
| Overall Study | COMPLETED | Ezetimibe 10 mg + Atorvastatin 40 mg | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01730040/flow